We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study Reveals Flaws in FDA, Industry Manufacturing Strategies
Study Reveals Flaws in FDA, Industry Manufacturing Strategies
October 13, 2006
Two established manufacturing practices favored by the FDA and industry, outsourcing and process analytical technology (PAT), are flawed and lead to lower-quality products, an academic study finds.